Trial NCT01650350

View at ClinicalTrials.gov 
Org. Study IDs: BrUOG 275

Last trial update was posted on 2022-03-04

MeSH Interventions

Naltrexone

MeSH Conditions

Carcinoma, Renal Cell Kidney Neoplasms Melanoma Prostatic Neoplasms

Other Conditions

Prostate Cancer Renal Cancer

Stopping Reasons

Study stopped 10/24/13 secondary to lack of patients/slow enrollment

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID